Cover Image

Statins for primary prevention of cardiovascular disease in Germany: benefits and costs

The reduction of LDL cholesterol lowers the risk of coronary and cerebrovascular events in individuals without manifest cardiovascular diseases. In Germany, statins at the expense of statutory health insurance had only been permitted for patients with atherosclerosis-related diseases or those at hig...

Full description

Saved in:
Bibliographic Details
Main Authors: Dressel, Alexander (Author) , Fath, Felix (Author) , Krämer, Bernhard (Author) , Klose, Gerald (Author) , März, Winfried (Author)
Format: Article (Journal)
Language:English
Published: 17 March 2025
In: Clinical research in cardiology
Year: 2025, Pages: 1-14
ISSN:1861-0692
DOI:10.1007/s00392-025-02608-5
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-025-02608-5
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00392-025-02608-5
Get full text
Author Notes:Alexander Dressel, Felix Fath, Bernhard K. Krämer, Gerald Klose, Winfried März
Description
Summary:The reduction of LDL cholesterol lowers the risk of coronary and cerebrovascular events in individuals without manifest cardiovascular diseases. In Germany, statins at the expense of statutory health insurance had only been permitted for patients with atherosclerosis-related diseases or those at high cardiovascular risk (over 20 percent event probability within the next 10 years, calculated using one of the “available risk calculators”). However, international guidelines recommend lower risk thresholds for the use of statins.
Item Description:Gesehen am 23.07.2025
Physical Description:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-025-02608-5

Similar Items